Amgen K.K
Amgen is committed to unlocking the potential of biology for patients suffering from serious illnesses by discovering, developing, manufacturing and delivering innovative human therapeutics. This approach begins by using tools like advanced human genetics to unravel the complexities of disease and understand the fundamentals of human biology.
See below for the Latest Amgen K.K News, Analysis, Profit Results, Share Price Information, and Commentary.
No more articles to show for this company
Join the community
Resource Center
Awards
Apr
10
Events
Event News
Global medical innovations and AI-driven solutions in the spotlight
Medical Taiwan 2024 drew 280 exhibitors from 10 countries, boosting tech integration in healthcare.